体外膜氧合治疗重度急性呼吸窘迫综合征:一项随机临床试验事后贝叶斯分析中死亡获益的后验概率
该研究是对EOLIA随机临床试验(249例极重度ARDS患者)的事后贝叶斯分析,比较早期ECMO(n=124,60天死亡率35%)与初始常规肺保护性通气并可选补救ECMO(n=125,60天死亡率46%)。通过设定不同先验分布(弱信息、中等热情、强怀疑、基于既往研究的贝叶斯荟萃分析),估计死亡获益的后验概率。弱信息先验下,60天死亡RR<1的后验概率为96%(RR 0.78,95%CrI 0.56-1.04),RR<0.67的概率18%,ARR≥2%的概率92%,ARR≥20%的概率2%。基于既往研究的先验下,RR 0.71(95%CrI 0.55-0.94),RR<1的概率99%,RR<0.67的概率48%。作者认为该分析可在多种假设下提供死亡获益的后验概率信息,有助于解读研究结果。
要点
- EOLIA试验249例极重度ARDS患者中,早期ECMO组60天死亡率35%(n=124),常规通气并可选补救ECMO组46%(n=125)。
- 弱信息先验下,60天死亡RR<1的后验概率为96%(RR 0.78,95%CrI 0.56-1.04),但RR<0.67的后验概率仅18%。
- 弱信息先验下ARR≥2%的后验概率92%,ARR≥20%的后验概率仅2%。
- 基于既往研究的先验下,RR 0.71(95%CrI 0.55-0.94),RR<1概率99%,RR<0.67概率48%,ARR≥2%概率98%,ARR≥20%概率4%。
- 强怀疑先验下,RR 0.88(95%CrI 0.71-1.09),RR<1概率88%,RR<0.67概率0%,ARR≥2%概率78%,ARR≥20%概率0%。
适用人群与场景
- 极重度ARDS患者,来自EOLIA随机临床试验,共249例,随机接受早期ECMO(n=124)或初始常规肺保护性通气并可选补救ECMO(n=125)。
研究设计与关键结果
- 研究类型:随机临床试验(EOLIA)的事后贝叶斯分析;样本量249例;人群为极重度ARDS患者。
- 干预与对照:早期ECMO(n=124)vs 初始常规肺保护性通气并可选补救ECMO(n=125)。
- 主要终点结果:60天死亡率早期ECMO组35% vs 常规通气组46%;弱信息先验下RR 0.78(95%CrI 0.56-1.04),RR<1的后验概率96%。
- 弱信息先验下,RR<0.67的后验概率18%,ARR≥2%的后验概率92%,ARR≥20%的后验概率2%。
- 中等热情先验(相当于264例患者、RR 0.78的试验信息)下,RR 0.78(95%CrI 0.63-0.96),RR<1概率99%,RR<0.67概率8%,ARR≥2%概率97%,ARR≥20%概率0%。
- 强怀疑先验(相当于264例患者、RR 1.0的试验信息)下,RR 0.88(95%CrI 0.71-1.09),RR<1概率88%,RR<0.67概率0%,ARR≥2%概率78%,ARR≥20%概率0%。
- 基于既往研究的先验下,RR 0.71(95%CrI 0.55-0.94),RR<1概率99%,RR<0.67概率48%,ARR≥2%概率98%,ARR≥20%概率4%。
证据类型、等级与局限
- 证据类型:随机临床试验(EOLIA)的事后贝叶斯分析。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为,该事后贝叶斯分析可在多种假设下提供早期ECMO对极重度ARDS患者死亡获益的后验概率信息,可能有助于解读EOLIA试验结果。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Bayesian analysis of clinical trial data may provide useful information to aid in study interpretation, especially when trial evidence suggests that the benefits of an intervention are uncertain, such as in a trial that evaluated early extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS).
OBJECTIVE: To demonstrate the potential utility of Bayesian analyses by estimating the posterior probability, under various assumptions, that early ECMO was associated with reduced mortality in patients with very severe ARDS in a randomized clinical trial (RCT).
DESIGN AND EVIDENCE: A post hoc Bayesian analysis of data from an RCT (ECMO to Rescue Lung Injury in Severe ARDS [EOLIA]) that included 249 patients with very severe ARDS who had been randomized to receive early ECMO (n = 124; mortality at 60 days, 35%) vs initial conventional lung-protective ventilation with the option for rescue ECMO (n = 125, mortality at 60 days, 46%). The trial was designed to detect an absolute risk reduction (ARR) of 20%, relative risk (RR) of 0.67. Statistical prior distributions were specified to represent varying levels of preexisting enthusiasm or skepticism for ECMO and by Bayesian meta-analysis of previously published studies (with downweighting to account for differences and quality between studies). The RR, credible interval (CrI), ARR, and probability of clinically important mortality benefit (varying from RR less than 1 to RR less than 0.67 and ARR from 2% or more to 20% or more) were estimated with Bayesian modeling.
FINDINGS: Combining a minimally informative prior distribution with the findings of the EOLIA trial, the posterior probability of RR less than 1 for mortality at 60 days after randomization was 96% (RR, 0.78 [95% CrI, 0.56-1.04]); the posterior probability of RR less than 0.67 was 18%, the probability of ARR of 2% or more was 92%, and the probability of ARR of 20% or more was 2%. With a moderately enthusiastic prior, equivalent to information from a trial of 264 patients with an RR of 0.78, the estimated RR was 0.78 (95% CrI, 0.63-0.96), the probability of RR less than 1 was 99%, the probability of RR less than 0.67 was 8%, the probability of ARR of 2% or more was 97%, and the probability of ARR of 20% or more was 0%. With a strongly skeptical prior, equivalent to information from a trial of 264 patients with an RR of 1.0, the estimated RR was 0.88 (95% CrI, 0.71-1.09), the probability of RR less than 1 was 88%, the probability of RR less than 0.67 was 0%, the probability of ARR of 2% or more was 78%, and the probability of ARR of 20% or more was 0%. If the prior was informed by previous studies, the estimated RR was 0.71 (95% CrI, 0.55-0.94), the probability of RR less than 1 was 99%, the probability of RR less than 0.67 was 48%, the probability of ARR of 2% or more was 98%, and the probability of ARR of 20% or more was 4%.
CONCLUSIONS AND RELEVANCE: Post hoc Bayesian analysis of data from a randomized clinical trial of early extracorporeal membrane oxygenation compared with conventional lung-protective ventilation with the option for rescue extracorporeal membrane oxygenation among patients with very severe acute respiratory distress syndrome provides information about the posterior probability of mortality benefit under a broad set of assumptions that may help inform interpretation of the study findings.
参考来源
- Goligher EC, Tomlinson G, Hajage D, et al. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial. JAMA. 2018. PMID: 30347031. doi:10.1001/jama.2018.14276
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。